Cargando…

Clinical markers of immunotherapy outcomes in advanced sarcoma

BACKGROUND: Despite immunotherapy’s promise in oncology, its use for sarcoma remains challenging. There are no sarcoma-specific biomarkers for immune checkpoint inhibitors (ICI). Previously, we reported our institutional experience highlighting ICI activity in 29 patients with sarcoma. In this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Husain, Marium, Quiroga, Dionisia, Kim, Han Gil, Lenobel, Scott, Xu, Menglin, Iwenofu, Hans, Chen, James L., Verschraegen, Claire, Liebner, David, Tinoco, Gabriel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080913/ https://www.ncbi.nlm.nih.gov/pubmed/37029351 http://dx.doi.org/10.1186/s12885-023-10758-w

Ejemplares similares

Emerging Trends in Immunotherapy for Adult Sarcomas
por: Husain, Marium, et al.
Publicado: (2023)

Activity of PD1 inhibitor therapy in advanced sarcoma: a single-center retrospective analysis
por: Quiroga, Dionisia, et al.
Publicado: (2020)

Case report: The power of immunotherapy in advanced cutaneous squamous cell carcinoma
por: Brockwell, Maximilian, et al.
Publicado: (2023)

Prospective Evaluation of the Concordance of Commercial Circulating Tumor DNA Alterations with Tumor-Based Sequencing across Multiple Soft Tissue Sarcoma Subtypes
por: Demoret, Bryce, et al.
Publicado: (2019)

An unusual presentation of extraskeletal vaginal Ewing sarcoma: A case report
por: Addison, Sarah, et al.
Publicado: (2023)

Randomized Prospective Trial Exploring the Impact of Structured Journaling in Patients With Sarcoma on the Management of Treatment-Related Adverse Events
por: Speece, N.J., et al.
Publicado: (2022)

An SS18::NEDD4 cutaneous spindled and epithelioid sarcoma: An hitherto unclassified cutaneous sarcoma, resembling epithelioid sarcoma with aggressive clinical behavior
por: Patton, Ashley, et al.
Publicado: (2022)

Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers
por: Li, Mingjia, et al.
Publicado: (2019)

Recent Advances in Immunotherapy for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma
por: Khorasanchi, Adam, et al.
Publicado: (2022)

Sorafenib-Induced Capillary Leak Syndrome
por: Kwon, Hyunwoo, et al.
Publicado: (2023)

A cancer disparities curriculum in a hematology/oncology fellowship program
por: Husain, Marium, et al.
Publicado: (2023)

Metastatic sporadic paraganglioma with EWSR1::CREM gene fusion: A unique molecular profile that expands the phenotypic diversity of the molecular landscape of the EWSR1::CREM gene fusion positive tumors
por: Javaid, Sehrish, et al.
Publicado: (2022)

Current Landscape of Immunotherapy for Advanced Sarcoma
por: Albarrán, Víctor, et al.
Publicado: (2023)

DR6 as a Diagnostic and Predictive Biomarker in Adult Sarcoma
por: Yang, Kun, et al.
Publicado: (2012)

Sarcoma Immunotherapy
por: Gouw, Launce G., et al.
Publicado: (2011)

Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials
por: Groisberg, Roman, et al.
Publicado: (2017)

Immunotherapy: Is it different for sarcomas?
por: Cleton-Jansen, Anne-Marie, et al.
Publicado: (2012)

Immunotherapy of Childhood Sarcomas
por: Roberts, Stephen S., et al.
Publicado: (2015)

NY-ESO-1 expression in sarcomas: A diagnostic marker and immunotherapy target
por: Lai, Jin-Ping, et al.
Publicado: (2012)

A Phase I Study of the Combination of Temsirolimus with Irinotecan for Metastatic Sarcoma
por: Verschraegen, Claire F., et al.
Publicado: (2013)

Role of immunotherapy in Ewing sarcoma
por: Morales, Erin, et al.
Publicado: (2020)

The Landscape of Immunotherapy for Retroperitoneal Sarcoma
por: Gingrich, Alicia A., et al.
Publicado: (2023)

HER2-positive Metastatic Melanoma: A Cautionary Tale!
por: Cui, Xiaoyan, et al.
Publicado: (2020)

The monoclonal antibody to cytotoxic T lymphocyte antigen 4, ipilimumab, in the treatment of melanoma
por: Verschraegen, Claire
Publicado: (2012)

Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications
por: Spakowicz, Daniel, et al.
Publicado: (2020)

VISTA in Soft Tissue Sarcomas: A Perspective for Immunotherapy?
por: Albertsmeier, Markus, et al.
Publicado: (2022)

BCG Immunotherapy of a Rat Sarcoma
por: Baldwin, R. W., et al.
Publicado: (1973)

Immunotherapy for Bone and Soft Tissue Sarcomas
por: Uehara, Takenori, et al.
Publicado: (2015)

Emerging trends in immunotherapy for pediatric sarcomas
por: Dyson, Kyle A., et al.
Publicado: (2019)

Immunotherapies in sarcoma: Updates and future perspectives
por: Ghosn, Marwan, et al.
Publicado: (2017)

Emerging mechanisms of immunotherapy resistance in sarcomas
por: Florou, Vaia, et al.
Publicado: (2022)

Is immunotherapy in the future of therapeutic management of sarcomas?
por: Clemente, Ottavia, et al.
Publicado: (2021)

Exploring the landscape of immunotherapy approaches in sarcomas
por: Pilavaki, Pampina, et al.
Publicado: (2023)

Identifying Opportunities and Challenges for Patients With Sarcoma as a Result of Comprehensive Genomic Profiling of Sarcoma Specimens
por: Hay, Margaret A., et al.
Publicado: (2020)

Case report: Pulmonary synovial sarcoma in a long-term survivor of childhood Hodgkin lymphoma
por: Shilo, Konstantin, et al.
Publicado: (2023)

Sarcoma osteogénico (Revisión Bibliográfica)/
por: Romero Tinoco, Pablo
Publicado: (1990)

Response to immunotherapy in a patient with advanced epithelioid sarcoma of adrenal gland: A case report
por: Wang, Jingwen, et al.
Publicado: (2022)

Intact cell MALDI-TOF mass spectrometric analysis of Chroococcidiopsis cyanobacteria for classification purposes and identification of possible marker proteins
por: Šebela, Marek, et al.
Publicado: (2018)

Seroprevalence of Kaposi Sarcoma–associated Herpesvirus and Other Serologic Markers in the Brazilian Amazon
por: Nascimento, Maria C., et al.
Publicado: (2009)

Sarcoma Immunotherapy: Past Approaches and Future Directions
por: D'Angelo, S. P., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_du8aukccuand8l0i7hqhauep9g